GSK PLC 13D and 13G filings for Turning Point Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2020-11-06 5:26 pm Purchase | 2020-10-29 | 13D | Turning Point Therapeutics, Inc. TPTX | GSK PLC | 2,273,618 4.900% | 4,958 (+0.22%) | Filing |